XENETIC BIOSCIENCES, INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $7.6M | $3.0M | $0 | $0 | $1.0M | $293.6K |
| Cost of Revenue | — | — | — | — | $0 | $0 | $44.8K |
| Gross Profit | — | — | — | — | $0 | $1.0M | $248.8K |
| Gross Margin | — | — | — | — | — | 100.0% | 84.7% |
| Operating Expenses | |||||||
| Research & Development | $2.9M | $4.1M | $43.7M | $3.4M | $6.3M | $3.1M | $1.9M |
| SG&A Expense | $4.4M | $6.9M | $6.7M | $6.4M | $6.6M | $6.6M | $3.6M |
| Operating Income | $-7.3M | $-3.6M | $-47.4M | $-9.8M | $-12.9M | $-8.6M | $-6.3M |
| Operating Margin | — | -47.1% | -1,581.0% | — | — | -861.3% | -2,160.8% |
| Interest Expense | — | $1.8K | $729.6K | $267.0K | $4.7K | $632 | $51.7K |
| Pretax Income | — | — | — | — | $-14.3M | $-8.6M | $-6.3M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net Income | $-7.3M | $-3.6M | $-54.2M | $-12.5M | $-14.3M | $-8.6M | $-6.3M |
| Net Margin | — | -47.4% | -1,806.9% | — | — | -857.9% | -2,155.4% |
| EPS (Basic) | $-9.66 | $-0.41 | $-7.84 | $-2.96 | $-0.11 | $-0.07 | $-0.05 |
| EPS (Diluted) | $-9.66 | $-0.41 | $-7.84 | $-2.96 | $-0.11 | $-0.07 | $-0.05 |
| Shares Outstanding (Basic) | 9.4M | 8.7M | 4.6M | 4.6M | 139.3M | 135.0M | 144.2M |
| Shares Outstanding (Diluted) | 9.4M | 8.7M | 4.6M | 4.6M | 139.3M | 135.0M | 144.2M |
| Dividends Per Share | — | — | — | — | — | — | — |